Recent advances in pulmonary vascular disease.

Abstract excerpt

There have been remarkable advances in our understanding of the pathobiology of pulmonary hypertension. A region on chromosome 2 encoding bone morphogenetic receptor type 2 has been identified to underlie familial and many cases of sporadic primary pulmonary arterial hypertension. The vasoactive mediators, discovered and defined by vascular biologists, have been translated into promising treatments of human...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antihypertensive Agents
• Share to Bone Morphogenetic Protein Receptors, Type II
• Share to Bronchodilator Agents